Saman Maleki Vareki - Concepedia

Author

Saman Maleki Vareki

Western University ORCID

Also Known As

S Maleki Vareki, S. Maleki Vareki, Saman Maleki Vareki, Samen Maleki Vareki

Publications

3.5K

Citations

H-Index

Concepts

All Affiliations

Western University Lawson Health Research Institute London Health Sciences Centre Centre Hospitalier de l’Université de Montréal St Joseph's Health Care

About

Saman Maleki Vareki is an author at Western University specializing in medicine, immunology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	607
2	Cell Biology	4	4	114
3	Health Sciences	2	2	64
4	Public Health	1	1	28
5	Hepatology	1	1	19

Saman Maleki Vareki

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhibitors Saman Maleki Vareki Journal for ImmunoTherapy of Cancer	2018	544
Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial Bertrand Routy, John Lenehan, Wilson H. Miller, Nature Medicine Tumor ImmunologyAnti-pd-1 ImmunotherapyCancer ImmunosurveillanceMedicineMelanoma	2023	385
TTI-621 (SIRPαFc): A CD47-Blocking Innate Immune Checkpoint Inhibitor with Broad Antitumor Activity and Minimal Erythrocyte Binding Penka S. Petrova, Natasja Nielsen Viller, Mark Wong, Clinical Cancer Research	2016	269
COTI-2, a novel small molecule that is active against multiple human cancer cell lines<i>in vitro</i>and<i>in vivo</i> Kowthar Y. Salim, Saman Maleki Vareki, Wayne R. Danter, Oncotarget	2016	150
Treatment-naïve HPV+ head and neck cancers display a T-cell-inflamed phenotype distinct from their HPV- counterparts that has implications for immunotherapy Steven F. Gameiro, Farhad Ghasemi, John W. Barrett, OncoImmunology	2018	138
CD1d‐independent activation of mouse and human <i>i</i>NKT cells by bacterial superantigens Jacqueline L. Hayworth, Delfina M. Mazzuca, Saman Maleki Vareki, Immunology and Cell Biology	2011	54
Indoleamine 2,3-dioxygenase mediates immune-independent human tumor cell resistance to olaparib, gamma radiation, and cisplatin Saman Maleki Vareki, Mateusz Rytelewski, René Figueredo, Oncotarget	2014	45
Novel anti-cancer drug COTI-2 synergizes with therapeutic agents and does not induce resistance or exhibit cross-resistance in human cancer cell lines Saman Maleki Vareki, Kowthar Y. Salim, Wayne R. Danter, PLoS ONE OncologyHealth SciencesMedicineImmune Checkpoint InhibitorMild Cross-resistance	2018	45
BMI, irAE, and gene expression signatures associate with resistance to immune-checkpoint inhibition and outcomes in renal cell carcinoma Brian Labadie, Ping Liu, Riyue Bao, Journal of Translational Medicine	2019	42
CD5 blockade enhances ex vivo CD8 <sup>+</sup> T cell activation and tumour cell cytotoxicity Faizah Alotaibi, Mateusz Rytelewski, René Figueredo, European Journal of Immunology	2020	40

Page 1